Advanced diagnostic and prognostic solutions for urological cancer care 

No matter which test(s) you receive from our growing portfolio of traditional and breakthrough products and services, rest assured they are backed by our superior clinical expertise and the
highest level of customer support.

Press Release

METAMARK GENETICS INITIATES CLINICAL USE OF ProMark™

Metamark Genetics, Inc. today announced that it has initiated clinical use of the company’s ProMark™ prognostic test to help guide the medical management of patients with early-stage prostate cancer.

read article
Press Release

Metamark Announces Appointment of Dr. Peter Blume-Jensen to its Scientific Advisory Board

Metamark today announced that its Chief Scientific Officer, Peter Blume-Jensen, M.D., Ph.D., will be joining a targeted therapeutics startup, and will continue working for Metamark as a member of the company’s Scientific Advisory Board and as a consultant.

read article
Displaying results 9-10 (of 12)
 |<  <  1 - 2 - 3 - 4 - 5 - 6  >  >|